Applied Cells

Applied Cells is a private, U.S.-based biotech firm founded in 2014, focused on revolutionizing cell isolation for the cell therapy and diagnostics sectors. Its flagship MARS platform employs a proprietary InFlow column-free magnetic separation technology, aiming to reduce the time, cost, and complexity of processes like CAR-T manufacturing, with a stated goal of achieving $10,000 cost of goods (COGS). The company has established strategic partnerships, achieved ISO 13485:2016 certification, and submitted regulatory filings (FDA Type II Master File), positioning itself as an enabling technology provider in the rapidly growing cell therapy space. It operates as a platform company, selling instruments and reagents for both research and GMP use.

MARS InFlow column-free magnetic cell isolation system for high-purity, high-recovery, scalable cell separation.

Applied Cells competes with large, established players like Miltenyi Biotec (MACS®), STEMCELL Technologies (EasySep™), and Bio-Rad in the magnetic cell separation market. Its differentiation is the column-free InFlow technology, which it positions as faster, more scalable, and more cost-effective than traditional column-based systems. It also faces competition from other novel separation technologies, such as acoustic, microfluidic, and affinity-based platforms.